Thus, our findings strengthen the therapeutic potential of targeting Nrf2/HO-1 axis activation in MG for the treatment of ischemic stroke and offer translational potential of clinical interventions for diabetic stroke. This evidence concerns the gene HMOX1 and ischemic stroke.